NeoGenomics (NEO) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to NeoGenomics (NEO) Tops Q1 EPS by 3c

NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter

April 30, 2019 7:05 AM EDT

FT. MYERS, FL / ACCESSWIRE / April 30, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter of 2019.

First Quarter 2019 Highlights:

Consolidated revenue increased 51% to $95.6 million Clinical Services revenue increased 51% to $86.2 million Pharma Services revenue increased 45% to $9.4 million Gross profit increased 73% to $47.1 million

Douglas M. VanOort, the Company's Chairman and CEO, commented, "We are certainly pleased with our very strong... More